Skip to main content

Table 4 Comparison of Prediction Score and other indicators in predicting the progression of advanced NSCLC

From: Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles

Variables

Cutoff

AUC 95% CI

Sensitivity

Specificity

PPV

NPV

P

Prediction Score

16

0.825 (0.715,0.934)

80.8%

88.3%

75.0%

91.4%

< 0.0001

total MPs, events/μL

2800

0.686 (0.559,0.813)

69.2%

68.3%

48.6%

83.7%

0.006

NMPs, events/μL

160

0.712 (0.598,0.827)

69.2%

65.0%

46.2%

83.0%

0.002

PMPs, events/μL

80

0.804 (0.706,0.903)

84.6%

68.3%

53.7%

91.1%

< 0.0001

NLR

3.3

0.648 (0.513,0.784)

57.7%

78.3%

53.6%

81.0%

0.029

CEA, ng/ml

5.0

0.652 (0.515,0.788)

69.2%

65.0%

46.2%

83.0%

0.026

CYFRA21-1, ng/ml

2.5

0.741 (0.628,0.855)

96.2%

43.3%

42.4%

96.3%

0.058

LDH, U/L

210

0.694 (0.576,0.812)

46.2%

85.0%

57.1%

78.5%

0.004

  1. PPV Positive predictive value, NPV Negative predictive value, MPs microparticals, NMPs neutrophil-derived microparticals, PMPs platelet-derived microparticles, CEA carcino-embryonic antigen, CYFRA-211 Cytokeratin 19 fragment, NLR neutrophil-lymphocyte ratio, LDH lactate dehydrogenase, CEA carcino-embryonic antigen